(19)
(11) EP 0 178 299 A1

(12)

(43) Date of publication:
23.04.1986 Bulletin 1986/17

(21) Application number: 84901535.0

(22) Date of filing: 21.03.1984
(51) International Patent Classification (IPC): 
A61K 9/ 20( . )
A61K 31/ 19( . )
A61K 9/ 22( . )
(86) International application number:
PCT/US1984/000431
(87) International publication number:
WO 1985/004099 (26.09.1985 Gazette 1985/21)
(84) Designated Contracting States:
AT BE CH DE FR GB LI LU NL SE

(71) Applicant: Key Pharmaceuticals, Inc.
Miami, Florida 33169 (US)

(72) Inventor:
  • HSIAO, Charles, H.
    Cooper City, FL 33328 (US)

(74) Representative: Werner, Hans-Karsten, Dr. 
Patentanwälte Von Kreisler-Selting-Werner Postfach 10 22 41
D-50462 Köln
D-50462 Köln (DE)

   


(54) SUSTAINED RELEASE ORAL DOSAGE FORM FOR NAPROXYN